A pharmaceuticals health care company.
H.R. 4432: Safe and Accurate Food Labeling Act of 2014.
Educated staff about FDA guidances, specifically with respect to glucose meters and certain medical foods.
Educated staff about FDA interim final rule dealing with infant formula.Legislative efforts to help accelerate the discovery, development and delivery of promising new treatments to patients (21st Century Cures). International trade issues related to nutrition. Monitored legislative efforts to reform the corporate tax system.

H.R.4438: American Research and Competitiveness Act of 2014. Education with respect to implementation issues in the Medicare Competitive Bidding program, specifically as it relates to access to brand name diabetes test strips.
Payments issues related to transcatheter mitral valve repair procedures in the Medicare IPPS Final Rule for FY 2015.
H.R. 2925: Strengthening Medicare Anti-Fraud Measures Act of 2013.Education about federal regulations related to "anti-switching" rules which prohibit contract suppliers from incentivizing Medicare beneficiaries to switch their current blood glucose monitor.
HCR - Health Issues TRD - Trade (domestic/foreign) TAX - Taxation/Internal Revenue Code MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX DARREN WILLCOX DARREN WILLCOX